The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of BioRay Biopharmaceutical Co., Ltd. 浙 江 博 銳 生 物 製 藥 股 份 有 限 公 司 (the "Company") (A joint stock company incorporated ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Hangzhou Diagens Biotechnology Co., Ltd. 杭州德適生物科技股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liabili ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. BioRay Biopharmaceutical Co., Ltd. 浙 江 博 銳 生 物 製 藥 股 份 有 限 公 司 (a joint stock company incorporated in the People's Republic of China with limited ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Hangzhou Diagens Biotechnology Co., Ltd. 杭州德適生物科技股份有限公司 (the "Company") (A joint stock company incorporated in the ...

(the "Company") (A joint stock company incorporated in the People's Republic of China with limited liability) WARNING The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information ...

Table of Contents As filed with the Securities and Exchange Commission on January 5, 2026. Registration No. 333-292283 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aktis Oncology, Inc. (Exact name of registrant as specified in its charter) Delaware 2834 85-2584233 (State or other jurisdiction of Incorporation or organization (Primary Standard Industrial Classification Code Number) (I.R.S. Employer ...

发行计划 - 公司拟公开发行6,034,482股普通股及初始可购买9,051,723股普通股的认股权证，零现金行使选择权时可购买24,113,286股[10] - 假设初始行使价格为每股1.39美元，为组合公开发行价格的120%[10] - 公司向特定购买者提供最多6,034,482份预融资认股权证，购买价为组合公开发行价格减0.0001美元，行使价格为每股0.0001美元[12] - 公司授予承销商45天选择权，可按每股1.1599美元购买最多905,172股普通股和/或初始可购买1,357,758股普通股的认股权证[17] 财务数据 - 2025和2024年前九个月，公司净亏损分别约为280万和540万美元[55] - 2024和2023财年，公司净亏损分别约为870万和550万美元[55] - 截至2025年9月30日和2024年12月31日，公司累计亏损分别约为2850万和2570万美元[55] - 截至2025年9月30日，公司流动负债约为110万美元，现金及现金等价物约为20万美元[55] 用户数据 - 2025年前九个月，4755名美国高中运动员及团体订阅签约日体育平台[40] 业务合并 - 2025年5月27日，公司与One Blockchain等签订业务合并协议，后续两次修订[44] - 业务合并包括两次合并，完成后签约日体育和One Blockchain成为BlockchAIn全资子公司[45] - 若2026财年BlockchAIn的EBITDA达或超2500万美元，向One Blockchain股东发行相当于交易结束时发行股份总数11.628%的或有股份[46] - BlockchAIn向Maxim Partners发行相当于交易企业总价值3.5%的普通股，若有或有股份，还将发行或有股份的3.5%[47] 资金用途 - 公司将使用特定允许融资所得款项支付相关直接费用、最高150万美元现有债务及咨询协议下负债、最高150万美元One Blockchain交易成本[49] - 交易结束时剩余现金的70%和100%待扣款项由公司留存，30%分配给BlockchAIn[49] - 公司拟将发行净收益中436.6997万美元用于签约日体育营运资金和一般公司用途，预留188.2285万美元用于One Blockchain营运资金和一般公司用途[72] 股份相关 - 2023年4月14日进行1比5反向股票拆分，2024年11月16日进行1比48反向股票拆分[20] - 自2024年9月18日至2025年12月22日，公司已向非Boustead方发行28.5万股普通股[54] - 此次公开发行，公司拟发售603.4482万股普通股及可发行股份，最多可发行2491.7061万股普通股[54] - 假设发行最大数量股份，公司需向Boustead发行323.2983万股额外终止股份；若超额配售权全部行使，则需发行371.3505万股[54] 其他要点 - 公司是“新兴成长型公司”，有资格享受减少的上市公司报告要求[21] - 签约日体育平台于2019年推出，支持足球、棒球、垒球和男女足球项目[39] - 2025年12月1日，BlockchAIn向美国证券交易委员会提交S - 4注册声明，12月23日修订[51] - 公司需向Boustead发行相当于向第三方发行普通股数量10.35%的额外终止股份[53] - 业务合并完成后，公司股东预计将拥有BlockchAIn约8.5%的普通股，One Blockchain证券持有人预计将拥有约88.3%，Maxim Group预计将拥有约3.2%[78][80][81] - 业务合并完成后，Jerry Tang将间接拥有合并后公司约61%的流通普通股，合并后公司将成为“受控公司”[82] - 投资者购买本次发行的普通股将立即产生每股0.52美元的摊薄[87] - 本次发行的认股权证和预融资认股权证没有公开交易市场，流动性将受到限制[74][88] - 公司普通股在纽约证券交易所美国板上市，代码为“SGN”[174] - 公司、董事、高管和部分股东需遵守锁定期协议，期限为发行结束后90天和业务合并结束后30天中的较短者[166][167] - 澳大利亚证券仅可向“成熟投资者”“专业投资者”等豁免投资者发售，豁免投资者认购的证券在配股日期后12个月内不得在澳销售[183][184] - 巴西证券发售不构成公开发行，未在巴西证券委员会注册，仅在不构成公开发行或分销的情况下发售[186] - 加拿大证券仅可出售给特定合格投资者，转售需符合豁免规定[187] - 香港证券仅可出售给“专业投资者”，或在不构成招股章程、公开发售或邀请的情况下发售[192] - 以色列文件不构成招股章程，证券仅可向合格投资者发售，合格投资者需提交书面确认[193] - 中国内地招股章程不得流通或分发，证券仅可在符合相关法律法规的情况下发售[195] - 瑞士证券不得公开发售，文件未按瑞士法规披露标准编制，未获瑞士监管机构批准[196][197]

As filed with the U.S. Securities and Exchange Commission on January 5, 2026 Registration No. 333-290602 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Cogency Global Inc. 122 East 42nd Street, 18th Floor New York, NY 10168 Phone: (800) 221-0102 Fax: (800) 944-6607 (Name, address, including zip code, and telephone number, including area code, of agent for service) AM ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Inmyshow Digital Technology (Group) Co., Ltd. 天下秀數字科技(集團)股份有限公司 (the "Company") (A joint stock company incorporated ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Montage Technology Co., Ltd. 瀾起科技股份有限公司 (the "Company") (A joint stock company ...